ZELLUNA IMMUNOTHERAPY AS
816823862ActivePioneering TCR-NK cell therapies to eliminate solid cancers safely.
Public Limited Liability Company (Biotechnology)zelluna.com
Overview
- 9
- Employees
- 53K NOK
- Revenue
- 2016
- Founded
Description
Zelluna is a biotechnology company dedicated to eradicating solid cancers through innovative immune therapies. Its core mission involves unleashing the immune system's power using pioneering T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This novel platform is desi...
Tags
B2BB2CProfessional ServicesPharmaceuticalsHealthTechPublicly Listed
Ultimovacs AB